Trial Profile
Faecal microbiota transplantation for relapsing Clostridium difficile infection.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 May 2019
Price :
$35
*
At a glance
- Drugs Fidaxomicin (Primary) ; Vancomycin
- Indications Clostridium difficile infections
- Focus Therapeutic Use
- 16 May 2019 Status changed from recruiting to completed.
- 08 Mar 2016 New trial record